OPDIVO: payments to doctors
Payments that named OPDIVO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $24.5M
- Providers
- 17,048
- Transactions
- 141,458
- Average per transaction
- $174
The per-transaction average — $174 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 17,048 providers the average total is $1,440, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | $24,506,313 | 99.8% |
| Bristol Myers Squibb | $43,321 | 0.2% |